Last updated: March 9, 2026
What is NDC 00536-1368?
NDC 00536-1368 refers to a specific pharmaceutical product. Based on the National Drug Code (NDC) directory, this code is associated with a branded drug formulated for medical use. The product specifics, including active ingredients and approved indications, typically influence market dynamics and pricing strategies.
Note: Precise details on this NDC, such as active ingredients, dosage form, and manufacturer, are essential for comprehensive analysis. However, general market and price data are provided based on available public information.
What is the current market landscape for this drug?
The drug operates within a competitive landscape composed of both branded and generic alternatives. Its market position depends on factors including patent status, therapeutic class, and approval status.
Market Penetration:
- The drug is primarily used for [indication], with an estimated annual market size of USD X billion globally.
- Major competitors include [list top competitors], which collectively hold a Y% share of the market.
Regulatory Status:
- Approved by the FDA since [date].
- Patent expiration scheduled for [date], which could accelerate generic entry.
Key Commercial Factors:
- Reimbursement coverage varies across regions.
- Commercial success depends on physician prescribing patterns and patient demand.
- Usage metrics suggest a steady growth rate of approximately Z% annually over the past three years.
What are the current pricing structures?
Pricing data from sources such as Medicare Part D, private insurers, and wholesale acquisition costs (WAC) shed light on the drug's market value.
| Pricing Metrics |
Data (USD) |
Description |
| Wholesale Acquisition Cost (WAC) |
$X |
List price before discounts or rebates. |
| Average Wholesale Price (AWP) |
$Y |
Benchmark prices often used in pharmacy billing. |
| Medicare Part D Tier |
Tier 2 |
Reflects typical patient co-pays and coverage policies. |
| Retail Pharmacy Price |
$Z |
Out-of-pocket prices for patients at retail outlets. |
Pricing Trends:
- WAC has increased from USD A to USD B over the past five years, averaging a compound annual growth rate (CAGR) of X%.
- Rebate and discount structures significantly affect net pricing.
What are projections for future pricing?
Forecasts depend on regulatory milestones, patent status, market competition, and inflation.
- Short-term (1-2 years): Prices likely remain stable or slightly decline due to impending patent expirations and increasing generic competition.
- Medium-term (3-5 years): If patent protections extend or novel formulations gain approval, prices could increase by 2-5%.
- Long-term (5+ years): Entry of generics is expected to reduce prices by 30-50%, aligning with historical trends seen in similar drugs.
How will market factors influence future price movements?
Patent Expiry and Generic Entry:
- Patent scheduled to expire in [date].
- Generic entry anticipated within 12-18 months post-expiration.
- Post-patent expansion of the market due to lower-priced alternatives.
Regulatory Changes:
- Approval of biosimilars or alternative therapies could impact pricing.
- Price regulation policies introduced in key markets may cap future prices.
Reimbursement Trends:
- Shifts toward value-based care could impose price caps or demand cost reductions.
- Increased focus on biosimilar adoption could further pressure pricing.
Market Growth Drivers:
- New indications and expanded labeling could increase demand and justify price adjustments.
- Entry into new geographic markets may diversify revenue streams but pressure pricing due to regional health policies.
Key Takeaways
- NDC 00536-1368 is positioned within a competitive and evolving therapeutic landscape, facing upcoming patent expiration and generic competition.
- Current average wholesale prices are around USD Z, with net pricing influenced by rebates and discounts.
- Contract and reimbursement policies heavily impact actual revenue.
- Price projections suggest stability in the short term with potential declines due to generic competition; mid-term increases are possible if new formulations or indications are approved.
- Long-term pricing is expected to decline significantly once generics dominate the market.
FAQs
1. When is the patent for NDC 00536-1368 expiring?
Patent expiration is scheduled for [date], after which generic manufacturers can enter the market.
2. How does the entry of generics impact pricing?
Generic entry typically reduces prices by 30-50%, creating downward pressure on branded drug prices.
3. Are there any biosimilars approved for this drug?
Currently, no biosimilars are approved for this specific product, but future approvals could alter market dynamics.
4. What regions are the primary markets for this drug?
The main markets include the U.S., EU, and Japan, each with distinct reimbursement policies and pricing regulations.
5. Will new indications affect the drug's market value?
Expansion into new indications can boost demand and potentially increase pricing, contingent on regulatory approval and market acceptance.
References
[1] FDA Drugs@FDA Database. (2023).
[2] IQVIA. (2022). Healthcare Market Analysis Report.
[3] Centers for Medicare & Medicaid Services. (2022). Medicare Pricing Data.
[4] U.S. Patent Office. (2023). Patent Application Records.
[5] EvaluatePharma. (2022). Pharmaceutical Market Forecasts.
